Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plant production systems for vaccines.

Stephen J Streatfield1, John A Howard

  • 1ProdiGene, Inc., 101 Gateway Boulevard, College Station, TX 77845, USA. sstreatfield@prodigene.com

Expert Review of Vaccines
|January 9, 2004
PubMed
Summary

Plant-based vaccines offer a cost-effective and scalable alternative for producing subunit vaccines. These plant-produced antigens can elicit protective immune responses and be delivered orally, reducing costs and improving accessibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Production of the High Value Pharmaceutical Target, Human Granulocyte-Colony Stimulating Factor, in Nicotiana benthamiana Is Improved by Co-Expression of the Transcriptional Regulator of the Unfolded Protein Response, bZIP60.

Plant biotechnology journal·2026
Same author

The Nicotiana benthamiana Biofactory.

Plant biotechnology journal·2026
Same author

Basic leucine zipper transcription activators - tools to improve production and quality of human erythropoietin in Nicotiana benthamiana.

Biotechnology journal·2024
Same author

Engineering of a plant-produced virus-like particle to improve the display of the Plasmodium falciparum Pfs25 antigen and transmission-blocking activity of the vaccine candidate.

Vaccine·2022
Same author

Facilitating viral vector movement enhances heterologous protein production in an established plant system.

Plant biotechnology journal·2022
Same author

Optimization of biomass and target protein yield for Phase III clinical trial to evaluate Angiotensin Converting Enzyme 2 expressed in lettuce chloroplasts to reduce SARS-CoV-2 infection and transmission.

Plant biotechnology journal·2022

Area of Science:

  • Biotechnology
  • Vaccinology
  • Plant molecular farming

Background:

  • Plants present a viable platform for the cost-effective production of subunit vaccines.
  • High antigen expression levels in plants are achievable for practical vaccine development.

Purpose of the Study:

  • To describe the technology for developing plant-based vaccines.
  • To review the advantages of plant-based vaccine technology.
  • To discuss challenges and future prospects for commercialization.

Main Methods:

  • Expression of various antigens in plant systems.
  • Evaluation of immunogenic responses to plant-produced antigens.
  • Assessment of oral delivery efficacy and protection conferred.

Main Results:

  • Plant-produced antigens can induce significant immunogenic responses.
  • Oral delivery of plant-based vaccines confers protection.
  • Plant-based vaccine production is scalable and cost-effective.

Conclusions:

  • Plant-based vaccines are a promising, economical, and scalable approach for human and animal health.
  • Oral delivery of plant-based vaccines reduces distribution costs.
  • Further development is needed to address commercialization roadblocks.

Related Experiment Videos